We are live on ! Find out more
FULC icon

Fulcrum Therapeutics
FULC

66 hedge funds and large institutions have $256M invested in Fulcrum Therapeutics in 2020 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 25 increasing their positions, 12 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

367% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 3

108% more repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 12

57% more capital invested

Capital invested by funds: $163M → $256M (+$92.8M)

20% more funds holding

Funds holding: 55 → 66 (+11)

5.72% more ownership

Funds ownership: 75.02% → 80.74% (+5.7%)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

Holders
66
Holders Change
+11
Holders Change %
+20%
% of All Funds
1.17%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
14
Increased
25
Reduced
12
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
RI
RTW Investments
New York
+$10.4M
2
IC
Ikarian Capital
Texas
+$4.95M
3
BlackRock
BlackRock
New York
+$4.34M
4
ACP
Acuta Capital Partners
California
+$3.4M
5
Alyeska Investment Group
Alyeska Investment Group
Illinois
+$2.76M

Top Sellers

Rank Fund Capital Flow
1
BC
Boxer Capital
California
-$5.6M
2
OM
Opaleye Management
Massachusetts
-$4.11M
3
CC
Casdin Capital
New York
-$2.26M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
-$1.94M
5
Fidelity Investments
Fidelity Investments
Massachusetts
-$978K
Name Holding Trade Value Shares
Change 		Change in
Stake
TGI
1
TRV GP III
Massachusetts
$69.8M – – –
TGI
2
TRV GP IV
Massachusetts
$27.4M – – –
RI
3
RTW Investments
New York
$24.3M +$10.4M +920,844 +80%
Fidelity Investments
4
Fidelity Investments
Massachusetts
$20.5M -$978K -86,500 -5%
Point72 Asset Management
5
Point72 Asset Management
Connecticut
$15.7M -$1.94M -171,877 -11%
CC
6
Casdin Capital
New York
$14.5M -$2.26M -200,000 -14%
BlackRock
7
BlackRock
New York
$12.2M +$4.34M +384,087 +58%
ACP
8
Acuta Capital Partners
California
$7.99M +$3.4M +301,000 +79%
AI
9
Alphabet Inc
California
$7.94M – – –
Vanguard Group
10
Vanguard Group
Pennsylvania
$7.74M +$618K +54,654 +9%
Alyeska Investment Group
11
Alyeska Investment Group
Illinois
$5.3M +$2.76M +244,040 +117%
IC
12
Ikarian Capital
Texas
$5.13M +$4.95M +437,700 New
HMC
13
Harvard Management Company
Massachusetts
$4.81M – – –
Bessemer Group
14
Bessemer Group
New Jersey
$3.35M – – –
BCM
15
Burrage Capital Management
Massachusetts
$3.18M -$223K -19,719 -7%
State Street
16
State Street
Massachusetts
$2.8M +$310K +27,394 +13%
Janus Henderson Group
17
Janus Henderson Group
United Kingdom
$2.69M +$593K +52,468 +30%
Geode Capital Management
18
Geode Capital Management
Massachusetts
$2.43M +$674K +59,587 +40%
Northern Trust
19
Northern Trust
Illinois
$2.23M +$134K +11,840 +7%
SCM
20
Sio Capital Management
New York
$1.71M +$1.65M +146,272 New
FT
21
Fiduciary Trust
Massachusetts
$1.46M – – –
N
22
Nuveen
North Carolina
$1.38M +$764K +67,598 +135%
Morgan Stanley
23
Morgan Stanley
New York
$1.16M +$760K +67,249 +212%
OM
24
Opaleye Management
Massachusetts
$1.03M -$4.11M -363,700 -80%
PIM
25
Platinum Investment Management
Australia
$978K – – –
1
2 3

FULC Hedge Fund Activity: Q4 2020 in Review

66 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Fulcrum Therapeutics (FULC) for Q4 2020, worth a combined $256M — up 57% from $163M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new FULC positions and 3 closed out — a net gain of 11 holders — while 25 added to existing stakes and 12 trimmed.

The largest buyer was RTW Investments, adding an estimated $10.4M. The largest seller was Boxer Capital, exiting entirely with an estimated $5.6M sold.

  • 66 institutional investors held Fulcrum Therapeutics (FULC) as of Q4 2020, up from 55 in Q3 2020.
  • Funds reported $256M of Fulcrum Therapeutics stock for Q4 2020, up 57% quarter-over-quarter.
  • 14 funds opened new Fulcrum Therapeutics positions in Q4 2020 and 3 closed out, a net change of +11 holders.
  • The largest Fulcrum Therapeutics buyer in Q4 2020 was RTW Investments, an estimated $10.4M added.
  • The largest Fulcrum Therapeutics seller in Q4 2020 was Boxer Capital, an estimated $5.6M sold.

Based on aggregated 13F filings for Q4 2020.